Mitapivat
| CAS No. | 1260075-17-9 | Cat. No. | BCP19727 |
| Name | Mitapivat | ||
| Synonyms | PKR-IN-1; PKM2 activator 1020; PKM2 activator;AG348;AG-348;AG 348; | ||
| Formula | C24H26N4O3S | M. Wt | 450.56 |
| Description | Mitapivat is an orally available, small-molecule, allosteric activator of the red cell isoform of pyruvate kinase (PK-R), with potential to improve hemolytic anemia in patients with pyruvate kinase deficiency (PKD). Upon oral administration, mitapivat binds to and activates PK-R, thereby enhancing glycolytic pathway activity, improving adenosine triphosphate (ATP) levels and reducing 2,3-diphosphoglycerate (2,3-DPG) levels. Mutations in PK-R cause deficiency in PK-R which prevents adequate red blood cell (RBC) glycolysis, leading to a buildup of the upstream glycolytic intermediate 2,3-DPG and deficiency in the PK-R product ATP. | ||
| Related Products | 2329710-91-8（Mitapivat sulfate anhydrous） | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | Pyruvate Kinase | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.